Background
Increasingly, women with HIV (WHIV) begin effective antiretroviral therapy (ART) prior to conception, resulting in long-term sustained viral suppression. This may lead to lower circulating anti-HIV antibody levels during pregnancy and subsequently reduced maternal HIV antibody transfer to the fetus in utero. The objective of this study was to determine time to seroreversion among infants who were HIV-exposed uninfected (HEU) according to maternal HIV disease control.
Methods
Prospective study of WHIV and their infants in the Centre maternel et infantile sur le SIDA Cohort (Montreal, Canada) between 2018-2024. WHIV were enrolled at first pregnancy visit, and their children were followed from birth until age 5. HIV-negative status in infants was confirmed with at least 2 negative HIV DNA PCR tests at or after two months of age. HIV IgG antibody assay was performed at 1, 2, 4-6 and 24 months of age (Biolytical INSTI HIV1/HIV2). HEU infants who were HIV IgG antibody negative prior to 5 months of age were considered early seroreverters. Bivariate analyses were conducted to determine the association between early seroreversion and maternal variables.
Results
241 mother-infant pairs were evaluated. The majority of infants (75%, n=185), were born to WHIV who initiated ART prior to conception. At the time of delivery, median maternal CD4 count was 576 cells/mm3 (420, 810), CD4/CD8 ratio was 0.92 (0.63,1.38), and 65% (n=156) of women had an HIV viral load <20 copies/mL throughout pregnancy. The median time to seroreversion among infants was 4.1months (4.0, 23.9); 38% (n=91) had early seroreversion, including 8% (n=20) who were seronegative prior to 3 months of age, and 6 (2.5%) seronegative by 1 month of age. Factors associated with early seroreversion were maternal CD4/CD8 ratio >1 vs. <1 at the time of delivery (OR 2.46 [1.3;4.7], p =0.004), duration of treatment>5 years vs. <5 years (OR 2.0 [1.0;4.1], p=0.02) and HIV viral load <20 copies/ml throughout pregnancy vs. any detectable viremia (OR 2.45 [1.2;4.9], p=0.006).
Conclusions
Early seroreverion occurred in over 30% of HEU infants, and was strongly associated with sustained maternal viral suppression during pregnancy and preconception ART. The rapid clearance of HIV-1 antibodies in this context highlights the potential for earlier exclusion of HIV infection in exposed infants, and may have future implications for HIV diagnostics in exposed infants.